Dizal (Jiangsu) Pharmaceutical Co Ltd Class A 688192
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ¥35.48
- Day Range
- ¥35.70–39.49
- 52-Week Range
- ¥24.82–54.58
- Bid/Ask
- ¥37.81 / ¥37.85
- Market Cap
- ¥15.72 Bil
- Volume/Avg
- 2.9 Mil / 1.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 52.69
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Dizal (Jiangsu) Pharmaceutical Co Ltd is engaged in the research and development, production and sales of innovative drugs.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 581
- Website
- http://www.dizalpharma.com
Comparables
Valuation
|
Metric
|
688192
|
603896
|
603858
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 18.81 | 36.15 |
Price/Book Value | 25.80 | 2.05 | 1.65 |
Price/Sales | 52.69 | 5.76 | 1.59 |
Price/Cash Flow | — | 12.20 | 17.05 |
Price/Earnings
688192
603896
603858
Financial Strength
|
Metric
|
688192
|
603896
|
603858
|
|---|---|---|---|
Quick Ratio | 1.69 | 3.21 | 0.48 |
Current Ratio | 1.87 | 3.70 | 1.28 |
Interest Coverage | −68.37 | 16.62 | 0.41 |
Quick Ratio
688192
603896
603858
Profitability
|
Metric
|
688192
|
603896
|
603858
|
|---|---|---|---|
Return on Assets (Normalized) | −61.83% | 7.55% | −0.45% |
Return on Equity (Normalized) | −107.62% | 11.00% | −0.83% |
Return on Invested Capital (Normalized) | −73.37% | 7.10% | −0.07% |
Return on Assets
688192
603896
603858
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Stxbpyxf | Tkht | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Zpwxybkk | Pnvkg | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Hqdqtptk | Mwbbz | $48.4 Bil | |||
| Viatris Inc
VTRS
| Wtxrprfb | Gzth | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Mqqbxmtfn | Xfvj | $13.5 Bil | |||
| Catalent Inc
CTLT
| Yzvbbbk | Vzxngs | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Plbjzxblx | Jsvqsv | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Flhqcslr | Yck | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Srqlmyqbv | Djh | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Gkdmjjj | Gpb | $2.3 Bil |
United States